Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis

Herpes zoster (HZ) is a neurotropic virus. We aimed to evaluate the association of HZ infection, protective effects of antiviral treatment or vaccination on dementia. A systematic search of PubMed, MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, and Cochrane CENTRAL was performed from January 1, 19...

Full description

Saved in:
Bibliographic Details
Main Authors: Fawziah Marra, Kyle Gomes, Emily Liu, Nirma Khatri Vadlamudi, Kathryn Richardson, Jacquelyn J. Cragg
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:Human Vaccines & Immunotherapeutics
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/21645515.2025.2546741
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849329618592464896
author Fawziah Marra
Kyle Gomes
Emily Liu
Nirma Khatri Vadlamudi
Kathryn Richardson
Jacquelyn J. Cragg
author_facet Fawziah Marra
Kyle Gomes
Emily Liu
Nirma Khatri Vadlamudi
Kathryn Richardson
Jacquelyn J. Cragg
author_sort Fawziah Marra
collection DOAJ
description Herpes zoster (HZ) is a neurotropic virus. We aimed to evaluate the association of HZ infection, protective effects of antiviral treatment or vaccination on dementia. A systematic search of PubMed, MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, and Cochrane CENTRAL was performed from January 1, 1996, to October 31, 2024. Observational studies evaluating HZ infection, antivirals, or vaccination and dementia risk were selected. Risk of bias was examined with the Newcastle-Ottawa scale. A random-effects meta-analysis was performed, with the rate ratio (RR) and corresponding 95% confidence intervals (CIs) being pooled for dementia. Presence of heterogeneity was assessed with I2, and differences by study-level characteristics were estimated using subgroup meta-analysis and meta-regression. Eighteen studies (N = 9.4 million) were included. Infection was associated with elevated risk of dementia (RR 1.14; 95% CI: 1.04, 1.25, I2 = 98%); this remained significant in the sensitivity analysis when the two case-control studies were removed (RR 1.17; 95% CI: 1.06, 1.30, I2 = 98%). Subgroup analysis based on sex, age, study population, bias scores, type of dementia or HZO did not show statistically significant differences in risk. Treatment with antivirals showed a small effect (RR 0.84; 95% CI: 0.71, 0.99, I2 = 73%), but prophylaxis with HZ vaccination was associated with a significantly lower risk (RR 0.68; 95% CI: 0.56, 0.83, I2 = 99%). We report a slightly raised dementia risk after HZ infection and reduced risks after antiviral treatment and prevention with vaccination. However, results should be interpreted with caution due to significant heterogeneity in pooled analyses.
format Article
id doaj-art-4e1b53f5285f46cd91a686d6382b0d3e
institution Kabale University
issn 2164-5515
2164-554X
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series Human Vaccines & Immunotherapeutics
spelling doaj-art-4e1b53f5285f46cd91a686d6382b0d3e2025-08-20T03:47:13ZengTaylor & Francis GroupHuman Vaccines & Immunotherapeutics2164-55152164-554X2025-12-0121110.1080/21645515.2025.2546741Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysisFawziah Marra0Kyle Gomes1Emily Liu2Nirma Khatri Vadlamudi3Kathryn Richardson4Jacquelyn J. Cragg5Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, CanadaFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, CanadaFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, CanadaDepartment of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL, USANorwich Epidemiology Centre, University of East Anglia, Norwich, UKFaculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, CanadaHerpes zoster (HZ) is a neurotropic virus. We aimed to evaluate the association of HZ infection, protective effects of antiviral treatment or vaccination on dementia. A systematic search of PubMed, MEDLINE, EMBASE, Scopus, Web of Science, CINAHL, and Cochrane CENTRAL was performed from January 1, 1996, to October 31, 2024. Observational studies evaluating HZ infection, antivirals, or vaccination and dementia risk were selected. Risk of bias was examined with the Newcastle-Ottawa scale. A random-effects meta-analysis was performed, with the rate ratio (RR) and corresponding 95% confidence intervals (CIs) being pooled for dementia. Presence of heterogeneity was assessed with I2, and differences by study-level characteristics were estimated using subgroup meta-analysis and meta-regression. Eighteen studies (N = 9.4 million) were included. Infection was associated with elevated risk of dementia (RR 1.14; 95% CI: 1.04, 1.25, I2 = 98%); this remained significant in the sensitivity analysis when the two case-control studies were removed (RR 1.17; 95% CI: 1.06, 1.30, I2 = 98%). Subgroup analysis based on sex, age, study population, bias scores, type of dementia or HZO did not show statistically significant differences in risk. Treatment with antivirals showed a small effect (RR 0.84; 95% CI: 0.71, 0.99, I2 = 73%), but prophylaxis with HZ vaccination was associated with a significantly lower risk (RR 0.68; 95% CI: 0.56, 0.83, I2 = 99%). We report a slightly raised dementia risk after HZ infection and reduced risks after antiviral treatment and prevention with vaccination. However, results should be interpreted with caution due to significant heterogeneity in pooled analyses.https://www.tandfonline.com/doi/10.1080/21645515.2025.2546741Cognitive disordersdementiavaricella zoster virus infectionchickenpoxherpes zostershingles
spellingShingle Fawziah Marra
Kyle Gomes
Emily Liu
Nirma Khatri Vadlamudi
Kathryn Richardson
Jacquelyn J. Cragg
Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis
Human Vaccines & Immunotherapeutics
Cognitive disorders
dementia
varicella zoster virus infection
chickenpox
herpes zoster
shingles
title Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis
title_full Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis
title_fullStr Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis
title_full_unstemmed Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis
title_short Effects of herpes zoster infection, antivirals and vaccination on risk of developing dementia: A systematic review and meta-analysis
title_sort effects of herpes zoster infection antivirals and vaccination on risk of developing dementia a systematic review and meta analysis
topic Cognitive disorders
dementia
varicella zoster virus infection
chickenpox
herpes zoster
shingles
url https://www.tandfonline.com/doi/10.1080/21645515.2025.2546741
work_keys_str_mv AT fawziahmarra effectsofherpeszosterinfectionantiviralsandvaccinationonriskofdevelopingdementiaasystematicreviewandmetaanalysis
AT kylegomes effectsofherpeszosterinfectionantiviralsandvaccinationonriskofdevelopingdementiaasystematicreviewandmetaanalysis
AT emilyliu effectsofherpeszosterinfectionantiviralsandvaccinationonriskofdevelopingdementiaasystematicreviewandmetaanalysis
AT nirmakhatrivadlamudi effectsofherpeszosterinfectionantiviralsandvaccinationonriskofdevelopingdementiaasystematicreviewandmetaanalysis
AT kathrynrichardson effectsofherpeszosterinfectionantiviralsandvaccinationonriskofdevelopingdementiaasystematicreviewandmetaanalysis
AT jacquelynjcragg effectsofherpeszosterinfectionantiviralsandvaccinationonriskofdevelopingdementiaasystematicreviewandmetaanalysis